A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.
Bianca BerghuisCaragh StapletonAnja C M SonsmaJanic HulstGerrit-Jan de HaanDick LindhoutRita Demurtasnull nullRoland KrauseChantal DepondtWolfram S KunzFederico ZaraPasquale StrianoJohn CraigPauls AuceAnthony G MarsonHreinn StefanssonTerence J O'BrienMichael R JohnsonGraeme J SillsStefan WolkingHolger LercheSanjay M SisodiyaJosemir W SanderGianpiero L CavalleriBobby P C KoelemanMark McCormackPublished in: Epilepsia open (2019)
Although we did not detect a genetic predictor of hyponatremia or CBZ metabolism in our cohort, our findings suggest that the determinants of CBZ metabolism are multifactorial.